Home / Pharmaceutical company intelligence
ARP (PVT) Limited logo
Pharmaceutical company intelligence

ARP products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Rawat · Pakistan

Islamabad/Rawat pharmaceutical manufacturer with a fully licensed manufacturing facility and nationwide sales and support network.

ARP products in Pakistan

ARP (PVT) Limited has 84 medicine presentations registered in Pakistan under 33 brands, covering 31 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Araxone (Ceftriaxone), Arixime (Cefixime), Arepine (Quetiapine) and Esitil (Escitalopram). 84 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation12 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date3 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
ARP (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
Plot No. 12 & 12A, Street W-3, National Industrial Zone (RCCI), Rawat, Islamabad, Pakistan
Phone
+92 51 4499103
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000682 ARP (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000682 84 linked products · source seen 12 Nov 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx88public portfolio records represented
REG77unique registrations represented
IDX84indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+4registry-only registrations
VER30registry-verified exact registrations
PKR84current validated price records
G31generic molecules in indexed catalogue
DF8dosage-form groups
TA9therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixARP (PVT) LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 13 Nov 2026Anti-infectives44 · 52%CNS & mental health24 · 29%Gastrointestinal & hepatology7 · 8%Oncology & immunology4 · 5%Respiratory & allergy1 · 1%Dermatology1 · 1%Fluids & supportive care1 · 1%Other therapeutic areas2 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioARP (PVT) LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 13 Nov 202684presentationsTablet38 · 45%Capsule16 · 19%Injection16 · 19%Suspension6 · 7%Infusion3 · 4%Cream2 · 2%Other forms3 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionARP (PVT) LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 13 Nov 202681comparable productsBelow peer median67 · 83%Near peer median10 · 12%Above peer median4 · 5%Company median price position-12.7%Lowest-price equivalents4Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsARP (PVT) LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/arp-pvt-limitedGenerated 13 Nov 2026Nabiqasim Industries (Pvt) Ltd.,25 shared81% overlapBio-Labs(Pvt) Ltd24 shared77% overlapPharmasol (Pvt) Ltd.22 shared71% overlapM/s. Genix Pharma (Pvt) Ltd.21 shared68% overlapNeutro Pharma (Pvt.) Ltd.,21 shared68% overlapCCL Pharmaceuticals (Pvt.) Limited19 shared61% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives44 products · 52%
CNS & mental health24 products · 29%
Gastrointestinal & hepatology7 products · 8%
Oncology & immunology4 products · 5%
Respiratory & allergy1 products · 1%
Dermatology1 products · 1%
Fluids & supportive care1 products · 1%
Hematology & thrombosis1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins15 products · 18%
Antipsychotics13 products · 15%
SSRI antidepressants11 products · 13%
Fluoroquinolone antibacterials7 products · 8%
Antifungals6 products · 7%
Macrolide antibacterials5 products · 6%
Immunosuppressants / immunomodulators4 products · 5%
Oxazolidinone antibacterials4 products · 5%
Formulation footprint

Dosage forms

Tablet38 products
Capsule16 products
Injection16 products
Suspension6 products
Infusion3 products
Cream2 products
Sachet2 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AraxoneCeftriaxone 7presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 AriximeCefixime 5presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #3 ArepineQuetiapine 4presentations 100 mg, 25 mg · Tablet #4 EsitilEscitalopram 4presentations 10 mg, 20 mg · Tablet #5 ImucurbTacrolimus 4presentations 0.5 mg, 1 mg · Capsule #6 InfecnilCiprofloxacin 4presentations 200 mg/100 mL, 250 mg, 500 mg, 750 mg · Infusion, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where ARP (PVT) Limited is priced against the market

81 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,361 products · 117 generics 25shared generics Bio-Labs(Pvt) Ltd234 products · 81 generics 24shared generics Pharmasol (Pvt) Ltd.252 products · 102 generics 22shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers73Distinct registrations among indexed, published, presentation-validated products only
Verified price observations84
Products with a verified price84
Products with multiple price observations0
Source records with multiple versions84
Latest portfolio source check22 Sep 2026
Latest effective price date3 Jul 2026
Latest source observation12 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

77 unique registration(s) · 84 indexed presentation(s) · 4 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Increph 40mg InjectionRegistry verified Pantoprazole (as sodium sesquihydrate) — — — 111838Official source ↗ No indexed price — —
Infecnil Ciprofloxacin 500 mg Tablet 1x10s 079459 PKR 356.14 PKR 35.61/tablet 🔒 Pharma Pro
Infecnil Ciprofloxacin 250 mg Tablet 1x10s 097399 PKR 215.35 PKR 21.54/tablet 🔒 Pharma Pro
Infecnil Ciprofloxacin 750 mg Tablet 1x10s 097400 PKR 412.29 PKR 41.23/tablet 🔒 Pharma Pro
Infecnil Ciprofloxacin 200 mg/100 mL IV infusion 100ml 099240 PKR 165.65 PKR 1.66/mL 🔒 Pharma Pro
Isoflox Levofloxacin 500 mg Tablet 1x10s 079460 PKR 689.09 PKR 68.91/tablet 🔒 Pharma Pro
Isoflox Levofloxacin 250 mg Tablet 1x10s 079461 PKR 414.13 PKR 41.41/tablet 🔒 Pharma Pro
Konxol Voriconazole 200 mg Tablet 10's 116410 PKR 2,035.08 PKR 203.51/tablet 🔒 Pharma Pro
Linvox Linezolid 600 mg Tablet 12s 098210 PKR 4,233.92 PKR 352.83/tablet 🔒 Pharma Pro
Linvox Linezolid 400 mg Tablet 12s 098222 PKR 2,617.09 PKR 218.09/tablet 🔒 Pharma Pro
Linvox Linezolid 600 mg/300 mL IV infusion 300ml 099242 PKR 1,075.52 PKR 3.59/mL 🔒 Pharma Pro
Linvox Linezolid 400 mg/200 mL IV infusion 200ml 099243 PKR 896.27 PKR 4.48/mL 🔒 Pharma Pro
Obsertin Sertraline 50 mg Tablet 30s 099201 PKR 1,253.09 PKR 41.77/tablet 🔒 Pharma Pro
Obsertin Sertraline 100 mg Tablet 20s 099202 PKR 1,658.51 PKR 82.93/tablet 🔒 Pharma Pro
Prevon Tabs Ondansetron 4 mg Tablet 1s 099182 PKR 85.47 PKR 85.47/tablet 🔒 Pharma Pro
Prevon Tabs Ondansetron 4 mg Tablet 10s 099182 PKR 854.74 PKR 85.47/tablet 🔒 Pharma Pro
Prevon Tabs Ondansetron 8 mg Tablet 12s 099183 PKR 1,709.47 PKR 142.46/tablet 🔒 Pharma Pro
Prevon Tabs Ondansetron 8 mg Tablet 10s 099183 PKR 1,424.56 PKR 142.46/tablet 🔒 Pharma Pro
Purox Cefuroxime 250 mg Injection 5s 080391 PKR 231.90 PKR 46.38/vial/unit 🔒 Pharma Pro
Purox Cefuroxime 250 mg Injection 1s 080391 PKR 46.37 PKR 46.37/vial/unit 🔒 Pharma Pro
Purox Cefuroxime 1.5 g Injection 1s 080392 PKR 298.16 PKR 298.16/vial/unit 🔒 Pharma Pro
Ramid-4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 150 mg + 75 mg + 400 mg + 275 mg Tablet 100's 116419 PKR 3,235.29 PKR 32.35/tablet 🔒 Pharma Pro
Respocure Clarithromycin 125 mg/5 mL Dry suspension 60ml 079477 PKR 369.39 PKR 6.16/mL 🔒 Pharma Pro
Respocure Clarithromycin 250 mg/5 mL Dry suspension 60ml 098217 PKR 609.57 PKR 10.16/mL 🔒 Pharma Pro
Retipro Terbinafine 1 % Cream 10g 079490 PKR 278.28 PKR 27.83/g 🔒 Pharma Pro
Roxidep Paroxetine 20 mg Tablet 10s 098202 PKR 510.87 PKR 51.09/tablet 🔒 Pharma Pro
Roxidep CR Paroxetine 25 mg Tablet 30s 099203 PKR 1,488.97 PKR 49.63/tablet 🔒 Pharma Pro
Roxidep CR Paroxetine 12.5 mg Tablet 30s 099204 PKR 893.76 PKR 29.79/tablet 🔒 Pharma Pro
Roxidep CR Paroxetine 37.5 mg Tablet 30s 099205 PKR 1,824.36 PKR 60.81/tablet No comparator
Roxidep CR Paroxetine 37.5 mg Controlled-release tablet 10s 099205 PKR 608.12 PKR 60.81/tablet No comparator
Symed Risperidone 1 mg Tablet 10s 099184 PKR 198.78 PKR 19.88/tablet 🔒 Pharma Pro
Symed Risperidone 2 mg Tablet 10s 099185 PKR 323.01 PKR 32.30/tablet 🔒 Pharma Pro
Symed Risperidone 3 mg Tablet 10s 099186 PKR 496.94 PKR 49.69/tablet 🔒 Pharma Pro
Symed Risperidone 4 mg Tablet 10s 099187 PKR 646.02 PKR 64.60/tablet 🔒 Pharma Pro
Trespor Itraconazole 100 mg Capsule 4s 099225 PKR 496.94 PKR 124.24/capsule 🔒 Pharma Pro
Zitpro Azithromycin 250 mg Capsule 1x10s 079468 PKR 422.40 PKR 42.24/capsule 🔒 Pharma Pro
Zitpro Azithromycin 200 mg/5 mL Suspension 15ml 079476 PKR 273.32 PKR 18.22/mL 🔒 Pharma Pro
Zitpro Azithromycin 500 mg Tablet 6s 098203 PKR 492.94 PKR 82.16/tablet 🔒 Pharma Pro
A to Z

All 33 ARP brands in Pakistan

  • Antibac-Skin Mupirocin · 2% cream
  • Aramox Moxifloxacin · 400 mg tablet
  • Arataxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Araxone Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
  • Arepine Quetiapine · 100 mg tablet, 25 mg tablet
  • Arepine XR Quetiapine · 150 mg tablet, 300 mg tablet
  • Arixime Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
  • Armutine Acetylcysteine · 200 mg sachet
  • Aromep Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
  • Calciderm Calcipotriol · 0.005% ointment
  • Co-flon Olanzapine + Fluoxetine · 12 mg + 25 mg capsule, 3 mg + 25 mg capsule, 6 mg + 25 mg capsule
  • Contrazole Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg/5 mL suspension
  • Electrofix Sodium chloride · 13.5 g sachet
  • Esitil Escitalopram · 10 mg tablet, 20 mg tablet
  • Ferochel Deferasirox · 500 mg tablet
  • Fetaclom Clomifene citrate · 50 mg tablet
  • Glyvanq Vancomycin · 1 g injection, 500 mg injection
  • Imucurb Tacrolimus · 0.5 mg capsule, 1 mg capsule
  • Infecnil Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
  • Isoflox Levofloxacin · 250 mg tablet, 500 mg tablet
  • Konxol Voriconazole · 200 mg tablet
  • Linvox Linezolid · 400 mg tablet, 400 mg/200 mL infusion, 600 mg tablet
  • Obsertin Sertraline · 100 mg tablet, 50 mg tablet
  • Prevon Tabs Ondansetron · 4 mg tablet, 8 mg tablet
  • Purox Cefuroxime · 1.5 g injection, 250 mg injection
  • Ramid-4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol · 150 mg + 75 mg + 400 mg + 275 mg tablet
  • Respocure Clarithromycin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
  • Retipro Terbinafine · 1 % cream
  • Roxidep Paroxetine · 20 mg tablet
  • Roxidep CR Paroxetine · 12.5 mg tablet, 25 mg tablet, 37.5 mg tablet
  • Symed Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
  • Trespor Itraconazole · 100 mg capsule
  • Zitpro Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
Questions

ARP: common questions

How many products does ARP have in Pakistan?

ARP (PVT) Limited has 84 registered medicine presentations in Pakistan, sold under 33 brands and covering 31 generic medicines.

What are the main brands of ARP?

By number of registered strengths and packs, its largest brands are Araxone (Ceftriaxone), Arixime (Cefixime), Arepine (Quetiapine), Esitil (Escitalopram) and Imucurb (Tacrolimus). This is not a sales ranking.

Which therapy areas does ARP cover?

The most products are in Anti-infectives (43), CNS & mental health (24), Gastrointestinal & hepatology (7), Oncology & immunology (4) and Dermatology (2).

Where can I see ARP medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). ARP (PVT) Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/arp-pvt-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9